Please enable JavaScript to continue using this application.

Compare $IPSC vs $LXEO | Chartloom

Compare

$IPSC vs $LXEO

Century Therapeutics Inc · Lexeo Therapeutics Inc

IPSC

Century Therapeutics Inc

LXEO

Lexeo Therapeutics Inc

Compare $IPSC vs $LXEO

Comparing Century Therapeutics Inc and Lexeo Therapeutics Inc

IPSCCentury Therapeutics Inc

LXEOLexeo Therapeutics Inc

IPSCCentury Therapeutics Inc

Market cap

$265M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

47.8%

52W performance

151.9%

FCF yield

-33.3%

LXEOLexeo Therapeutics Inc

Market cap

$254M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-66.4%

52W performance

-59.8%

FCF yield

-35.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IPSC

LXEO

Detailed metrics comparison

IPSC

Century Therapeutics Inc

LXEO

Lexeo Therapeutics Inc

Market Cap

IPSC$265M

LXEO$254M

Enterprise Value

IPSC$215M

LXEO$161M

Price

IPSC$1.47

LXEO$3.23

P/E Ratio

IPSCN/A

LXEON/A

P/S Ratio

IPSC2.41x

LXEO535.16x

EV/Sales

IPSC1.98x

LXEO0.00x

EV/EBITDA

IPSC0.00x

LXEO0.00x

P/B Ratio

IPSC1.19x

LXEO1.23x

P/FCF Ratio

IPSCN/A

LXEON/A

EV/FCF

IPSC-2.44x

LXEO-1.82x

PEG Ratio

IPSCN/A

LXEON/A

Forward P/E (NTM)

IPSCN/A

LXEON/A

Forward P/S (NTM)

IPSCN/A

LXEON/A

Revenue (TTM)

IPSC$0

LXEO$0

Revenue Growth (YoY)

IPSC-100.0%

LXEON/A

Forward Rev Growth

IPSC385.7%

LXEO466.0%

Gross Margin (TTM)

IPSC0.0%

LXEO0.0%

Operating Margin (TTM)

IPSC0.0%

LXEO0.0%

EBITDA Margin (TTM)

IPSC0.0%

LXEO0.0%

Net Margin (TTM)

IPSC0.0%

LXEO0.0%

FCF Margin (TTM)

IPSCN/A

LXEON/A

Net Income (TTM)

IPSC$-110M

LXEO$-87M

FCF (TTM)

IPSC$-88M

LXEO$-89M

EPS (TTM)

IPSC-$0.53

LXEO-$1.02

ROE (TTM)

IPSC-5276.0%

LXEO-4185.0%

ROA (TTM)

IPSC-4059.0%

LXEO-3803.0%

ROIC (TTM)

IPSC-5276.0%

LXEO-4169.0%

Cash

IPSC$50M

LXEO$93M

Debt

IPSC$0

LXEO$584K

Net Cash/Debt

IPSC$50M

LXEO$92M

Current Ratio (TTM)

IPSC8.28x

LXEO13.89x

Quick Ratio (TTM)

IPSC7.94x

LXEO13.49x

Debt/Equity (TTM)

IPSC0.00x

LXEO0.00x

Debt/Assets (TTM)

IPSC0.0%

LXEO0.0%

Interest Coverage (TTM)

IPSCN/A

LXEON/A

Net Debt/EBITDA (TTM)

IPSC0.00x

LXEO0.00x

Beta

IPSC1.74

LXEO1.62

52W Performance

IPSC151.9%

LXEO-59.8%

YTD Performance

IPSC47.8%

LXEO-66.4%

% from 52W High

IPSC-51.6%

LXEO-70.6%

% from 52W Low

IPSC237.9%

LXEO8.4%

Asset Turnover (TTM)

IPSC0.31x

LXEO0.00x

FCF Yield (TTM)

IPSC-33.3%

LXEO-35.0%

Earnings Yield (TTM)

IPSC-41.4%

LXEO-34.4%

Dividend Yield (TTM)

IPSCN/A

LXEON/A

Rule of 40

IPSC-100.0

LXEO0.0

EV/GP/RG

IPSCN/A

LXEON/A

Ticker research

View IPSC research View LXEO research

Metric	IPSC Century Therapeutics Inc	LXEO Lexeo Therapeutics Inc
Market & Valuation
Market Cap	$265M	$254M
Enterprise Value	$215M	$161M
Price	$1.47	$3.23
P/E Ratio	N/A	N/A
P/S Ratio	2.41x	535.16x
EV/Sales	1.98x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.23x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-1.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	385.7%	466.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-110M	$-87M
FCF (TTM)	$-88M	$-89M
EPS (TTM)	-$0.53	-$1.02
ROE (TTM)	-5276.0%	-4185.0%
ROA (TTM)	-4059.0%	-3803.0%
ROIC (TTM)	-5276.0%	-4169.0%
Financial Health
Cash	$50M	$93M
Debt	$0	$584K
Net Cash/Debt	$50M	$92M
Current Ratio (TTM)	8.28x	13.89x
Quick Ratio (TTM)	7.94x	13.49x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	1.62
52W Performance	151.9%	-59.8%
YTD Performance	47.8%	-66.4%
% from 52W High	-51.6%	-70.6%
% from 52W Low	237.9%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.00x
FCF Yield (TTM)	-33.3%	-35.0%
Earnings Yield (TTM)	-41.4%	-34.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View LXEO research

Valuation

P/S Ratio

IPSC

2.41x

LXEO

535.16x

EV/FCF

IPSC

-2.44x

LXEO

-1.82x

Growth & revenue

Revenue Growth TTM

IPSC

-100.0%

Forward Revenue Growth

LXEO

466.0%

IPSC

385.7%

Profitability & performance

Gross Margin

IPSC

0.0%

LXEO

0.0%

ROE

LXEO

-4185.0%

IPSC

-5276.0%

FCF Yield %

IPSC

-33.3%

LXEO

-35.0%

52-Week Performance

IPSC

151.9%

LXEO

-59.8%

Detailed metrics comparison

IPSC

Century Therapeutics Inc

LXEO

Lexeo Therapeutics Inc

Market Cap

IPSC$265M

LXEO$254M

Enterprise Value

IPSC$215M

LXEO$161M

Price

IPSC$1.47

LXEO$3.23

P/E Ratio

IPSCN/A

LXEON/A

P/S Ratio

IPSC2.41x

LXEO535.16x

EV/Sales

IPSC1.98x

LXEO0.00x

EV/EBITDA

IPSC0.00x

LXEO0.00x

P/B Ratio

IPSC1.19x

LXEO1.23x

P/FCF Ratio

IPSCN/A

LXEON/A

EV/FCF

IPSC-2.44x

LXEO-1.82x

PEG Ratio

IPSCN/A

LXEON/A

Forward P/E (NTM)

IPSCN/A

LXEON/A

Forward P/S (NTM)

IPSCN/A

LXEON/A

Revenue (TTM)

IPSC$0

LXEO$0

Revenue Growth (YoY)

IPSC-100.0%

LXEON/A

Forward Rev Growth

IPSC385.7%

LXEO466.0%

Gross Margin (TTM)

IPSC0.0%

LXEO0.0%

Operating Margin (TTM)

IPSC0.0%

LXEO0.0%

EBITDA Margin (TTM)

IPSC0.0%

LXEO0.0%

Net Margin (TTM)

IPSC0.0%

LXEO0.0%

FCF Margin (TTM)

IPSCN/A

LXEON/A

Net Income (TTM)

IPSC$-110M

LXEO$-87M

FCF (TTM)

IPSC$-88M

LXEO$-89M

EPS (TTM)

IPSC-$0.53

LXEO-$1.02

ROE (TTM)

IPSC-5276.0%

LXEO-4185.0%

ROA (TTM)

IPSC-4059.0%

LXEO-3803.0%

ROIC (TTM)

IPSC-5276.0%

LXEO-4169.0%

Cash

IPSC$50M

LXEO$93M

Debt

IPSC$0

LXEO$584K

Net Cash/Debt

IPSC$50M

LXEO$92M

Current Ratio (TTM)

IPSC8.28x

LXEO13.89x

Quick Ratio (TTM)

IPSC7.94x

LXEO13.49x

Debt/Equity (TTM)

IPSC0.00x

LXEO0.00x

Debt/Assets (TTM)

IPSC0.0%

LXEO0.0%

Interest Coverage (TTM)

IPSCN/A

LXEON/A

Net Debt/EBITDA (TTM)

IPSC0.00x

LXEO0.00x

Beta

IPSC1.74

LXEO1.62

52W Performance

IPSC151.9%

LXEO-59.8%

YTD Performance

IPSC47.8%

LXEO-66.4%

% from 52W High

IPSC-51.6%

LXEO-70.6%

% from 52W Low

IPSC237.9%

LXEO8.4%

Asset Turnover (TTM)

IPSC0.31x

LXEO0.00x

FCF Yield (TTM)

IPSC-33.3%

LXEO-35.0%

Earnings Yield (TTM)

IPSC-41.4%

LXEO-34.4%

Dividend Yield (TTM)

IPSCN/A

LXEON/A

Rule of 40

IPSC-100.0

LXEO0.0

EV/GP/RG

IPSCN/A

LXEON/A

Ticker research

View IPSC research View LXEO research

Metric	IPSC Century Therapeutics Inc	LXEO Lexeo Therapeutics Inc
Market & Valuation
Market Cap	$265M	$254M
Enterprise Value	$215M	$161M
Price	$1.47	$3.23
P/E Ratio	N/A	N/A
P/S Ratio	2.41x	535.16x
EV/Sales	1.98x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.23x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.44x	-1.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	385.7%	466.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-110M	$-87M
FCF (TTM)	$-88M	$-89M
EPS (TTM)	-$0.53	-$1.02
ROE (TTM)	-5276.0%	-4185.0%
ROA (TTM)	-4059.0%	-3803.0%
ROIC (TTM)	-5276.0%	-4169.0%
Financial Health
Cash	$50M	$93M
Debt	$0	$584K
Net Cash/Debt	$50M	$92M
Current Ratio (TTM)	8.28x	13.89x
Quick Ratio (TTM)	7.94x	13.49x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	1.62
52W Performance	151.9%	-59.8%
YTD Performance	47.8%	-66.4%
% from 52W High	-51.6%	-70.6%
% from 52W Low	237.9%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.00x
FCF Yield (TTM)	-33.3%	-35.0%
Earnings Yield (TTM)	-41.4%	-34.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IPSC research	View LXEO research